Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

NxStage Celebrates Seven Year Anniversary of IU Health's Home Hemodialysis Program and Patient Milestones

August 15, 2011 6:51 am | by Bio-Medicine.Org | News | Comments

LAWRENCE, Mass., Aug. 15, 2011 /- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, is celebrating Indiana University Health's (IU Health) seventh anniversary of its program to offer home hemodialysis to patients with the NxStage System...

Fujifilm Launches Ultrasound Product Line in U.S.

August 15, 2011 6:51 am | by Bio-Medicine.Org | News | Comments

GRAPEVINE, Texas, Aug. 15, 2011 /- Today at the 2011 AHRA FUJIFILM Medical Systems U.S.A., Inc. announced the company's entry into the portable ultrasound market with the commercial availability of the Fazone CB®. Designed to meet the needs of the point-of-care and mobile healthcare...

Dehaier Medical Announces Record Second Quarter 2011 Financial Results

August 15, 2011 6:51 am | by Bio-Medicine.Org | News | Comments

BEIJING, Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced its financial...

Advertisement

Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society

August 15, 2011 6:51 am | by Bio-Medicine.Org | News | Comments

MINNETONKA, Minn., Aug. 15, 2011 /- Uroplasty, Inc. (Nasdaq: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of two clinical studies using Uroplasty's Urgent® PC...

Adeona Reports Second Quarter 2011 Financial Results

August 15, 2011 6:49 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., Aug. 15, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, today reported its second quarter 2011 financial results for the period ended June 30, 2011, as well as updates since the...

THA Group Partners with Cardiocom Telehealth

August 15, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Aug. 15, 2011 /- THA Group, a free standing in-home health company serving coastal Georgia and South Carolina, announced that it will be partnering with Cardiocom® to expand its chronic telehealth program providing advanced home telehealth technology to patients with...

Pulmatrix pulls in $14M in Series B round

August 15, 2011 5:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Pulmatrix Inc., a Lexington biotechnology company focused on respiratory diseases, has taken in $14 million in a Series B1 funding round, from all previous including Polaris Venture Partners, 5AM Ventures, Arch Venture Partners, and Novartis Venture Fund.

Student's doctoral success leads to bright future

August 15, 2011 3:49 am | by Arizona State University | News | Comments

Siddhartha Angadi is stepping into his last year of the Physical Activity, Nutrition and Wellness Ph.D. program with a strong foot forward. read more

Advertisement

Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease

August 15, 2011 2:37 am | by Bio-Medicine.Org | News | Comments

NOVATO, Calif., Aug. 15, 2011 /- Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced the dosing of the first patient in a Phase 1 study of UX001 for hereditary inclusion body myopathy (HIBM)....

Daniels Sharpsmart Expands U.S. Presence With New Pennsylvania Facility

August 15, 2011 2:37 am | by Bio-Medicine.Org | News | Comments

EASTON, Pa., Aug. 15, 2011 /- Daniels Sharpsmart Inc., the world's largest provider of reusable systems for sharps disposal and the second largest company in the medical waste disposal industry in the United States, will be celebrating the launch of their new facility at 925 Conroy Place...

Daniels Sharpsmart Expands U.S. Presence With New Facility in Midwest

August 15, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

STURTEVANT, Wis., Aug. 15, 2011 /- Daniels Sharpsmart Inc., the world's largest provider of reusable systems for sharps disposal and the second largest company in the medical waste disposal industry in the United States, will be celebrating the launch of their new facility at 1340...

BD Launches Family of Syringes Which Addresses Environmental Impact and Meets a Variety of Clinical Needs

August 15, 2011 12:46 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., Aug. 15, 2011 /- BD Medical, a segment of BD (Becton, Dickinson and Company), today announced the launch of the BD Emerald™ Syringe portfolio designed to meet emerging needs in medication delivery while addressing environmental impact by reducing material. The...

Quest Diagnostics Declares Quarterly Cash Dividend

August 13, 2011 9:40 pm | by Bio-Medicine.Org | News | Comments

MADISON, N.J., Aug. 12, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on October 24, 2011,...

Advertisement

Robotic Surgery: Clever Marketing or Life-Saving Technology

August 13, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 13, 2011 /- Robotics are helping surgeons make great strides in the medical arena, and the advanced technology used in robotic prostatectomy procedures delivers many benefits to both surgeon and patient. However, in recent news, there is some scrutiny on the frequency of...

Conserving Your Momentum

August 13, 2011 8:33 am | by Diagnostic Imaging | News | Comments

Remember your education in physics? No, not the stuff from your radiology residency; I'm talking about undergraduate classes, or even earlier. Chances are you thought more than a couple of times about how irrelevant this stuff was going to be, once you got into med school. I know I did.

MR Shines Light on Pancreatic Flow

August 13, 2011 7:47 am | by Diagnostic Imaging | News | Comments

A formidably named bit of technology can open a new window into pancreas function, according to a new study in the journal Radiology. Serial magnetic resonance cholangiopancreatography (MRCP) with a spatially selective inversion-recovery (IR) pulse can provide insights into pancreatic...

FDA Pushes Registry Data to Help Meet Postmarket Requirements

August 12, 2011 4:33 pm | by U.S. Food & Drug Administration | News | Comments

CDRH is pushing a proposal to increase the use of registries to help meet device postmarket surveillance requirements.

FDA May Require Supplier Quality Agreements in Upcoming Guidance

August 12, 2011 4:32 pm | by U.S. Food & Drug Administration | News | Comments

The FDA is considering requiring quality agreements between medical product manufacturers and their suppliers as part of its push for tighter control of the supply chain, an FDA consumer safety officer says.

HeartWare to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference

August 12, 2011 10:45 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass and SYDNEY, Aug. 12, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug...

PLC Systems Reports Second Quarter 2011 Results

August 12, 2011 7:45 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., Aug. 12, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today reported financial results for the three- and six month periods ended June 30, 2011. These results only include the company's RenalGuard® operations,...

Misonix Announces New Distribution Agreement for Australia and New Zealand

August 12, 2011 7:44 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Aug. 12, 2011 /- Misonix, Inc. (NASDAQ: MSON ), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other...

University Hospitals and Centerre Healthcare Announce Joint Venture to Open Comprehensive Inpatient Rehabilitation Hospital

August 12, 2011 7:42 am | by Bio-Medicine.Org | News | Comments

CLEVELAND and NASHVILLE, Tenn., Aug. 12, 2011 /- University Hospitals (UH) in Cleveland, OH, and Nashville-based Centerre Healthcare Corporation announced today a joint venture to construct a comprehensive inpatient rehabilitation hospital in Beachwood, OH. Scheduled for completion in...

Public Workshop - Mobile Medical Applications Draft Guidance, September 12-13, 2011

August 12, 2011 7:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA on July 19, 2011 announced it is seeking input on its oversight approach for certain mobile applications specific to medicine or health care called mobile medical applications (apps) that are designed for use on smartphones and other mobile...

Public Meeting - Recommendations Proposed in Institute of Medicine Report: Medical Devices and the Public's Health, The FDA 510(k) Clearance Process at 35 Years, Septembe...

August 12, 2011 7:30 am | by U.S. Food & Drug Administration | News | Comments

The purpose of the meeting is to encourage public comment on the recommendations proposed in the Institute of Medicine (IOM) report.

Pacira Pharmaceuticals, Inc. to Present at Wedbush Securities 2011 Life Sciences Management Access Conference

August 12, 2011 4:46 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Aug. 12, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that David Stack, president and chief executive officer of Pacira Pharmaceuticals, is scheduled to present at the Wedbush Securities 2011 Life...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading